Prokidney (PROK) Assets (2021 - 2026)
Prokidney (PROK) reported Assets of $292.8 million for Q1 2026, down 27.9% year-over-year from $406.1 million in Q1 2025, and down 12.75% on a QoQ basis from $335.6 million in Q4 2025.
Prokidney (PROK) has 6 years of Assets data on file, last reported at $292.8 million in Q1 2026.
- Quarterly Assets fell 27.9% year-over-year to $292.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $292.8 million (down 27.9% YoY) and the FY2025 annual result came in at $335.6 million, down 23.92% from the prior year.
- Assets fell to $292.8 million in Q1 2026 per PROK's latest filing, from $335.6 million in the prior quarter.
- Across five years, Assets topped out at $532.4 million in Q3 2022 and bottomed at $250.8 million in Q1 2022.
- The 5-year median for Assets is $420.6 million (2023), against an average of $409.7 million.
- The widest annual swing landed in 2022, when Assets jumped 40202.15%; it then decreased 27.9% in 2026.
- Tracing PROK's Assets over 5 years: stood at $518.0 million in 2022, then fell by 18.81% to $420.6 million in 2023, then rose by 4.88% to $441.1 million in 2024, then fell by 23.92% to $335.6 million in 2025, then dropped by 12.75% to $292.8 million in 2026.
- Per Business Quant, the three latest PROK Assets figures stand at $292.8 million (Q1 2026), $335.6 million (Q4 2025), and $351.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 14.93 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 37.37 Mn |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 1.73 Bn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 78.88 Mn |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 33.89 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 26.48 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 23.64 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 40.87 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 5.13 Bn |
| 10 | Prokidney | 259.72 Mn | 1.55 Bn | - | 292.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 292.78 Mn |
| Dec 31, 2025 | 335.57 Mn |
| Sep 30, 2025 | 351.61 Mn |
| Jun 30, 2025 | 372.13 Mn |
| Mar 31, 2025 | 406.06 Mn |
| Dec 31, 2024 | 441.07 Mn |
| Sep 30, 2024 | 474.79 Mn |
| Jun 30, 2024 | 499.16 Mn |
| Mar 31, 2024 | 387.76 Mn |
| Dec 31, 2023 | 420.55 Mn |
| Sep 30, 2023 | 451.81 Mn |
| Jun 30, 2023 | 484.22 Mn |
| Mar 31, 2023 | 495.15 Mn |
| Dec 31, 2022 | 518.00 Mn |
| Sep 30, 2022 | 532.44 Mn |
| Jun 30, 2022 | 251.00 Mn |
| Mar 31, 2022 | 250.75 Mn |
| Dec 31, 2021 | 40.30 Mn |
| Sep 30, 2021 | 251.44 Mn |
| Jun 30, 2021 | 622,804.00 |